
|Articles|August 1, 2003
- Pharmaceutical Executive-08-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
about 23 years ago
The $46 Million Manabout 23 years ago
More Than Just a Pretty Faceabout 23 years ago
Managing the Innovatorabout 23 years ago
Protecting IP Throughout the Product LifecycleAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
3
Who Pays for Tariff Driven Input Cost Increases?
4
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
5



